Interleukin-10 (IL-10) genotypes in inflammatory bowel disease

被引:148
作者
Tagore, A
Gonsalkorale, WM
Pravica, V
Hajeer, AH
McMahon, R
Whorwell, PJ
Sinnott, PJ
Hutchinson, IV
机构
[1] Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
[2] Univ S Manchester Hosp, Dept Med, Manchester M20 8LR, Lancs, England
[3] Univ Manchester, ARC Epidemiol Res Unit, Manchester, Lancs, England
[4] Univ Manchester, Dept Pathol Sci, Manchester, Lancs, England
来源
TISSUE ANTIGENS | 1999年 / 54卷 / 04期
关键词
biallelic; Crohn's disease; IBD; IL-10; polymorphisms; ulcerative colitis;
D O I
10.1034/j.1399-0039.1999.540408.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin-10 (IL-10) is an anti-inflammatory cytokine. Its production in humans is under genetic control, and genotype defines high or low producers of this cytokine. This study addresses the hypothesis that idiopathic inflammatory bowel disease (IBD) patients are more likely to have the low IL-10 producer genotype and phenotype. DNA was extracted from blood cells of patients with Crohn's disease (CD) or with ulcerative colitis (UC) for IL-10 genotyping. The frequency of the high IL-10 producer allele (-1082*G) was decreased in the whole IBD group (41% vs. 51%, P=0.03) and in the UC patients compared with normal controls (37% vs. 51%; P= 0.04). Hence, there appears to be an association between the IL-10 genotypes and IBD. This suggests that individuals genetically predisposed to produce less PL-IO are at a higher risk of developing LED, in particular, UC.
引用
收藏
页码:386 / 390
页数:5
相关论文
共 31 条
[1]   Tumour necrosis factor and inflammatory bowel disease [J].
Armstrong, AM ;
Gardiner, KR ;
Kirk, SJ ;
Halliday, MI ;
Rowlands, BJ .
BRITISH JOURNAL OF SURGERY, 1997, 84 (08) :1051-1058
[2]   Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation [J].
Awad, MR ;
El-Gamel, A ;
Hasleton, P ;
Turner, DM ;
Sinnott, PJ ;
Hutchinson, IV .
TRANSPLANTATION, 1998, 66 (08) :1014-1020
[3]  
BEST WR, 1976, GASTROENTEROLOGY, V70, P439
[4]   Inflammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus [J].
Cahill, RJ ;
Foltz, CJ ;
Fox, JG ;
Dangler, CA ;
Powrie, F ;
Schauer, DB .
INFECTION AND IMMUNITY, 1997, 65 (08) :3126-3131
[5]   Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease [J].
Cominelli, F ;
Pizarro, TT .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 :49-53
[6]  
Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO
[7]  
2-Y
[8]   T helper cell 1-type CD4(+) T cells, but not B cells, mediate colitis in interleukin 10-deficient mice [J].
Davidson, NJ ;
Leach, MW ;
Fort, MM ;
ThompsonSnipes, L ;
Kuhn, R ;
Muller, W ;
Berg, DJ ;
Rennick, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :241-251
[9]  
Dieleman LA, 1997, SCAND J GASTROENTERO, V32, P99
[10]  
Duchmann R, 1997, Z GASTROENTEROL, V35, P337